Cytomegalovirus reactivation and tumour necrosis factor
WD Döcke, E Fietze, U Syrbe, R von Baehr, HD Volk… - The Lancet, 1994 - Elsevier
WD Döcke, E Fietze, U Syrbe, R von Baehr, HD Volk, S Prösch, V Kimel, DH Krüger…
The Lancet, 1994•ElsevierTumour necrosis factor-alpha (TNF) stimulates cytomegalo-virus (CMV) activity in a
transfected human monocytic cell line. We assessed whether this finding is relevant in vivo
by evaluating the frequency of active CMV infection in patients with diseases that enhance
plasma TNF, in septic disease, peripheral blood mononuclear cells of almost all patients
studied were positive for CMV. Furthermore, CMV antigenaemia and enhanced plasma TNF
occurred in many patients with liver cirrhosis, common variable immuno-deficiency, and B …
transfected human monocytic cell line. We assessed whether this finding is relevant in vivo
by evaluating the frequency of active CMV infection in patients with diseases that enhance
plasma TNF, in septic disease, peripheral blood mononuclear cells of almost all patients
studied were positive for CMV. Furthermore, CMV antigenaemia and enhanced plasma TNF
occurred in many patients with liver cirrhosis, common variable immuno-deficiency, and B …
Abstract
Tumour necrosis factor-alpha (TNF) stimulates cytomegalo-virus (CMV) activity in a transfected human monocytic cell line. We assessed whether this finding is relevant in vivo by evaluating the frequency of active CMV infection in patients with diseases that enhance plasma TNF, in septic disease, peripheral blood mononuclear cells of almost all patients studied were positive for CMV. Furthermore, CMV antigenaemia and enhanced plasma TNF occurred in many patients with liver cirrhosis, common variable immuno-deficiency, and B-cell chronic lymphocytic leukaemia. Thus, TNF may have a central role in CMV reactivation.
Elsevier